Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on the Detection of Donor Derived Cell Free DNA （cfDNA）for the Early-stage Diagnosis of Acute Rejection Reaction Post Kidney Transplantation

NCT03759535 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT03759535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03759535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on the Detection of Donor Derived Cell Free DNA （cfDNA）for the Early-stage Diagnosis of Acute Rejection Reaction Post Kidney Transplantation
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2018
Completion date
September 30, 2021
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant failure and rejection